University of New Mexico
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of New Mexico sits in the top decile of US sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count).
University of New Mexico: 168 sponsored US clinical trials, 2 recruiting.
University of New Mexico sponsors 168 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 123 completed. 15 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage).
Top-decile sponsor footprint
University of New Mexico ranks in the top decile of sponsors by registered trial count (#172 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
123 of 165 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (74.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
168 total, page 4 of 4
Lung Cancer Case Registry and Tissue Resource
NCT00250848
Comparison of Blood Pressure Medications on Metabolism
NCT00642434
A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department
NCT00429832
Arm Function and Quality of Life Following Mastectomy.
NCT00379106
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
NCT00277082
Metformin Compared to Glyburide in Gestational Diabetes
NCT00965991
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
NCT00249990
Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
NCT00250068
The Effects of Two Days of Bedrest on Insulin Resistance in Type 2 Diabetics
NCT00508599
Dysregulated Tyrosine Kinase Signaling in Leukemia
NCT00277056
Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer
NCT00320983
SGO Society of Gynecologic Oncologists Data Outcomes Project
NCT00320996
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
NCT00277069
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.
NCT00277004
Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer
NCT00003584
Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
NCT00003585
Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
NCT00002721
Scheduled Triple-lumen Central Venous Catheter Exchange: A Prospective Controlled Randomized Study
NCT00250809
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 11 |
| Phase 3 | 4 |
| Phase 4 | 11 |
What is open in the University of New Mexico pipeline
2 recruiting of 168 indexed (1% open); 123 completed (73%).
Phase mix: 15 late (III/IV) vs 25 early (I/II) (early-phase heavy).
Therapeutic area indexing for this sponsor is limited in the public registry.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of New Mexico: open-pipeline peers nationwide
Peers matched on 168 registered trials and 1% open enrollment, not the therapeutic-area sidebar.
University of New Mexico sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 168 trials (± recruiting share)
- Astellas Pharma Global Development · 168 trials · 11% recruiting
- Bausch Health Americas · 168 trials · 4% recruiting
- Seattle Children's Hospital · 168 trials · 17% recruiting
- Sumitomo Pharma America · 168 trials · 4% recruiting
Sponsors near 1% open enrollment (± trial volume)
- Astellas Pharma · 1% recruiting · 165 trials
- Abbott Nutrition · 1% recruiting · 89 trials
- Baxalta now part of Shire · 1% recruiting · 74 trials
- Power Life Sciences · 2% recruiting · 62 trials
Related
What to do with this University of New Mexico page
168 registered trials is a research-attention snapshot, not an endorsement of University of New Mexico or any single study.
- 2 of University of New Mexico's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of New Mexico pipeline card: 168 registered trials from official public datasets.Report a data error.